- So thrilled that our work on tertiary lymphoid structures in glioblastoma is out today in @NatComms https://t.co/2Xc8M8aOah! Thanks to all the co-authors and especially @AleVaccaro93 (Co-first!) and @AnnaDimberg (PI) for your hard work!!
- 🎉Congratulations to all 3 finalists of the @CoimbraGroup #ThreeMinutesThesis #3MT final! 👏Favour Onyeogaziri, Robin Amsters & Dounia Ziyati!!!Time for the judging panel to decide... 😰🤔🙄🎥Follow here: https://t.co/Mz1HLhB7Cv pic.twitter.com/y5TkoOTYLo
- Proud of Mark Richards new paper in Cell Reports which shows molecular leakage from preselected sites in venules, shared between histamine and VEGF! https://t.co/yxfsIUz6Gw. Have a look!
Welcome to IGP
The department conducts advanced research and education in areas such as clinical immunology, medical genetics and genomics, pathology, oncology, neuro-oncology, vascular biology, molecular tools and medical radiation sciences.
Some of our activities are integrated with clinics at Uppsala University Hospital.
Find examples of research at the department in Our research in images
New research findings from IGP
Important role of genetics for age at first sex and birth
An international research team, where Marcel den Hoed has participated, has identified hundreds of genetic variants that are linked with age at first sex and birth of the first child. The study shows that a combination of genetics, social predictors and the environment drives early or late reproductive onset and that it can be related to later life diseases.
Structures discovered in brain cancer patients can help fight tumours
Researchers at IGP have discovered lymph node-like structures close to the tumour in brain cancer patients, where immune cells can be activated to attack the tumour. They also found that immunotherapy enhanced the formation of these structures in a mouse model. This discovery suggests new opportunities to regulate the anti-tumour response of the immune system.
Immune cells in the tumour associated with worse prognosis for mantle cell lymphoma
Tumour cells can affect immune cells in the body so that the tumour is not attacked by the immune defence. In a new research paper from IGP, the researchers show that some types of immune cells are more common in more aggressive tumours of the cancer form mantle cell lymphoma. The findings suggest a possibility to develop drugs that can improve the prognosis for mantle cell lymphoma patients.